Home > News > Biophan Technologies Files 8-K Providing NASA Conference Call Transcript
August 24th, 2004
Biophan Technologies Files 8-K Providing NASA Conference Call Transcript
Biophan Technologies, Inc. announced today that it has filed an 8-K with the Securities and Exchange Commission providing a transcript of the Company's investor conference call on Thursday, August 19, during which Biophan CEO Michael Weiner detailed to investors and other interested parties information on the Biophan / NASA's Ames Research Center agreement calling for characterization and joint development of high-density, nano-engineered thermoelectric materials for use with implantable medical devices.
Nanoscale worms provide new route to nano-necklace structures March 29th, 2015
Solving molybdenum disulfide's 'thin' problem: Research team increases material's light emission by twelve times March 29th, 2015
A first glimpse inside a macroscopic quantum state March 28th, 2015
DFG to Establish One Clinical Research Unit and Five Research Units: New Projects to Investigate Complications in Pregnancy, Particle Physics, Nanoparticles, Implants and Transport Planning / Approximately 13 Million Euros in Funding for an Initial Three-Year Period March 28th, 2015